Polymer conjugates of acridine-type anticancer drugs with pH-controlled activation

Bioorg Med Chem. 2012 Jul 1;20(13):4056-63. doi: 10.1016/j.bmc.2012.05.007. Epub 2012 May 14.

Abstract

Acridines are potent DNA-intercalating anticancer agents with high in vivo anticancer effectiveness, but also severe side effects. We synthesized five 9-anilinoacridine-type drugs and their conjugates with biocompatible water-soluble hydrazide polymer carrier. All of the synthesized acridine drugs retained their in vitro antiproliferative properties. Their polymer conjugates were sufficiently stable at pH 7.4 (model of pH in blood plasma) while releasing free drugs at pH 5.0 (model of pH in endosomes). After internalization of the conjugates, the free drugs were released and are visible in cell nuclei by fluorescence microscopy. Their intercalation ability was proven using a competitive ethidium bromide displacement assay.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amsacrine / analogs & derivatives*
  • Amsacrine / chemistry
  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / toxicity
  • Cell Line, Tumor
  • Cell Nucleus / metabolism
  • Cell Survival / drug effects
  • DNA / metabolism
  • Drug Carriers / chemical synthesis
  • Drug Carriers / chemistry*
  • Hep G2 Cells
  • Humans
  • Hydrogen-Ion Concentration
  • Intercalating Agents / chemical synthesis
  • Intercalating Agents / chemistry
  • Intercalating Agents / toxicity
  • Microscopy, Fluorescence
  • Polymers / chemical synthesis
  • Polymers / chemistry*
  • Water / chemistry

Substances

  • Antineoplastic Agents
  • Drug Carriers
  • Intercalating Agents
  • Polymers
  • Amsacrine
  • Water
  • 9-anilinoacridine
  • DNA
  • calf thymus DNA